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JMNI SCHOLARSHIP HONORS SHACKELFORD 
The Washington University Medical Center 
Alumni Association created the Distinguished 
Alumni Scholarship Program (DASP) in 1989 to 
annually provide first-year medical students with 
four years of full-tutition funding. The scholarships 
are named after distinguished alumni who are 
Washington University faculty. A 1998 Distin- 
guished Alumni Scholarship honors Gary Shack- 
elford, MD, professor of radiology and of pediatrics. 
The Shackelford Scholarship was awarded to 
Hanna Wunsch, a 1997 Harvard University graduate 
who began her medical training at Washington Uni- 
versity School of Medicine in the fall of 1998. 
Shackelford has been a member of the MIR 
community since 1969 when he began three years of 
diagnostic radiology residency and served as the 
1971-1972 chief resident. He joined the Institute 
faculty in 1972 as an instructor in radiology and was 
later appointed professor of radiology (1982) and 
professor of pediatrics (1983). An active participant 
in student and resident education, Shackelford 
served as director of Medical Student Education in 
Radiology (1977-1981) and director of Diagnostic 
Radiology Resident Training (1981-1988). He 
received the 1995 Distinguished Teaching Award, 
which is presented annually by the senior radiology 
residents. He is a fellow of the American College of 
Radiology and a member of the Radiological Society 
of North America and the Society for Pediatric 
Radiology (member of the Board of Directors, 1981 
to 1983). 
Other MIR faculty honored by DASP are (1995) 
Barbara Monsees, MD, chief of breast imaging; 
(1996) Ronald Evens, MD, director of the Institute; 
and (1997) Barry Siegel, MD, director of the Divi- 
sion of Nuclear Medicine. 
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NEW STUDIES YIELD RESULTS IN TREATING CERVICAL 
CANCER 
Based on five landmark research studies, the 
National Cancer Institute reports that the survival 
rate for women with advanced cervical cancer is 
dramatically increased when chemotherapy is 
added to standard radiation treatment. 
VIRTUAL C0L0N0SC0PY, A 3-D VISUALIZATION OF 
THE COLON 
Researchers are evaluating a rapidly advancing 
technology called spiral computed tomography 
colonography to screen colorectal polyps, the pre- 
cursors of colon cancer, by using two- and three- 
dimensional images of the colon. 
UTERINE ARTERY EMBOLIZATION: AN ALTERNATIVE 
TO HYSTERECTOMY 
The Washington University Comprehensive 
Fibroid Center offers a nonsurgical alternative to 
hysterectomy for women with uterine fibroids, the 
most common benign tumors in women in the 
United States. 
THE ART OF IMAGING 
Musculoskeletal radiologists are using the same 
rapid prototyping technology that replicates a 
patient's anatomy to assist in the The Saint Louis 




ON THE COVER: 
According to the National Cancer Institute, colon cancer is a highly treatable 
and often curable disease when detected early, yet it remains the second most 
common cause of cancer death in the United States. Dr. Elizabeth McFarland 
and a team of clinical and technical investigators are studying the reliability of 









Mallinckrodt Institute is 
one of 42 institutions partici- 
pating in a new cooperative 
group committed to multi- 
center cancer-related clinical 
trials. Established in 
November 1998 and funded 
by the National Cancer Insti- 
tute, the American College of 
Radiology Oncologic Imag- 
ing Network (ACRIN) is an 
integrated collaboration 
comprised of researchers 
from radiology, other med- 
ical specialties, and related 
basic and clinical sciences. 
ACRIN's goal is to "improve 
the health of cancer patients 
through the advancement of 
diagnostic imaging and 
image-guided interventional 
procedures." 
Among its specific 
objectives, ACRIN intends to 
evaluate innovative diagnos- 
tic imaging and image-guided 
treatment methods for can- 
cer patients; reduce health- 
care costs while improving 
the effectiveness of patient 
care; define and disseminate 
standards of operation for 
the high quality use of imag- 
ing technology; and, through 
clinical trials, faciltiate the 
early availability of new, 
potentially valuable tech- 
nologies to a broader range 
of patients. 
MIR faculty are active 
members of ACRIN. 
■ Jeffrey Brown, MD, associ- 
ate professor of radiology, 
director of clinical 
research, and codirector 
of magnetic resonance 
imaging, is the Institute's 
representative to ACRIN 
and is a member of the 
Receptor Imaging and 
Delivery Systems 
Committee. 
i William Middleton, MD, 
professor of radiology and 
head of ultrasonography, 
is a member of the Ultra- 
sound Committee. 
David Piwnica-Worms, 
MD, PhD, professor of 
radiology and of molecu- 
lar biology and pharma- 
cology and director of the 
molecular pharmacology 
laboratory, chairs the 
Receptor Imaging and 
Delivery Systems Commit- 
tee and is a member of the 
Research Strategy Com- 
mittee. He also is a mem- 
ber of the Basic Sciences 
and Molecular Technolo- 
gies Committee. 
Barry Siegel, MD, profes- 
sor of radiology and of 
medicine and director of 
the Division of Nuclear 
Medicine, chairs the 
Nuclear Medicine/ 
SPECT/PET Committee 
and is a member of the 
Research Strategy 
Committee. 
Marilyn Siegel, MD, pro- 
fessor of radiology and of 
pediatrics, chairs the Pedi- 
atrics Committee and is a 
member of the Research 
Strategy Committee. 
Todd Wasserman, MD, 
professor of radiology, is 
chairman of the Radiation 
Oncology Committee of 





Gilbert Jost, MD, director 
of the Division of Diagnostic 
Radiology, was elected to a 
three-year term as chairman of 
the Radiological Society of 
North America's (RSNA) Elec- 
tronic Communications Com- 
mittee (ECC). Jost, who is a 
professor of radiology and of 
computer science, will guide 
the ECC as it oversees RSNA's 
initiatives to improve the 
exchange of data among 
radiology information and 
imaging systems. The commit- 
tee's 15 members are responsi- 
ble for evaluating computer 
software and hardware, mag- 
netic and optical data, storage 
devices, and electronic data 
transmission. 
"In order to efficiently 
provide patients with optimal 
care, physicians must be able 
to retrieve data from many 
sources, which requires the 
complete integration of med- 
ical information systems," 
says Jost. 
Under Jost's leadership, 
the ECC will continue to pro- 
mote enterprise-wide informa- 
tion sharing through an RSNA 
program called Integrating the 
Healthcare Enterprise (THE). 
In partnership with the Health- 
care Information and Manage- 
ment Systems Society, EHE is 
working on a standards 
process among systems that 
will allow various elements of 
a patient's medical history to 






magazine annually publishes 
a listing of the "Top Cancer 
Doctors" in the United 
States. The magazine's 
March 1999 issue narrowed 
the field to feature those 
doctors who "provide the 
most expert treatment and 
are the leading clinicians for 
lung, breast, and colon can- 
cer in women." The 318 
physicians were those cited 
most often in the 1,200 doc- 
tors nominated on surveys 
sent to surgical, medical, and 
radiation oncology depart- 
ment heads and section 
chiefs at major U.S. medical 
centers. Nominators could 
not submit physicians from 
their own institution. 
Three MIR faculty were 
among the experts: 
■ Radiation oncology, colon 
cancer—Robert Myerson, 
MD, PhD, professor of 
radiology. 
■ Radiation oncology, breast 
cancer and lung cancer— 
Carlos Perez, MD, profes- 
sor of radiology and 
director of the Radiation 
Oncology Center. 
■ Radiation oncology, breasi 
cancer—Marie Taylor, 
MD, instructor in radiol- 
ogy and chief of Breast 
Cancer Service. 
ra 






Since 1965, the 
"Selected List of Books and 
Journals for the Small Med- 
ical Library"—later called 
the "Brandon List" for its 
author and now the "Bran- 
don/Hill List" to include its 
coauthor—has been the 
standard resource for hospi- 
tal library collections. 
Endorsed by the Joint Com- 
mission on Accreditation of 
Healthcare Organizations, 
the list contains the most 
current and authoritative 
information for the practic- 
ing clinician and serves as a 
buying guide for health sci- 
ences librarians. 
The list of journals and 
textbooks appears biennially 
in the Bulletin of the Med- 
ical Library Association 
and has traditionally been 
used as a planning tool for 
developing or updating a 
library print collection in a 
hospital or facility involved 
primarily in patient care. A 
recent Brandon/Hill List 
included two radiology text- 
books authored or edited by 
Mallinckrodt Institute 
faculty. 
Pitfalls, Variants, and 
Artifacts in Body MR Imag- 
ing, authored by Scott 
Mirowitz, MD, associate pro- 
fessor of radiology, radiolo- 
gist-in-chief at Barnes-Jewish 
Hospital north, and codirec- 
tor of body magnetic reso- 
nance imaging, is a reference 
of the wide range of MRI 
artifacts and anatomic vari- 
ants that can be mistaken for 
pathology. Published in 
1996, the book provides clin- 
cially relevant methodology 
for making informed, accu- 
rate diagnoses. 
Pediatric Sonography, 
now in its second edition, 
was edited by Marilyn Siegel, 
MD, professor of radiology 
and of pediatrics. This com- 
prehensive text on the pedi- 
atric applications of 
sonography includes up-to- 
date information on the gray- 
scale and Doppler imaging 
approach to a variety of dis- 
eases and the use of sonog- 
raphy in biopsy and 
treatment. Book chapters 
were authored by Siegel and 
doctors Thomas Herman, 
associate professor of radiol- 
ogy; William McAlister, pro- 
fessor of radiology and of 
pediatrics and chief of pedi- 
atric radiology; Gary Shack- 
elford, professor of radiology 
and of pediatrics; William 
Middleton, professor of 
radiology and head of ultra- 
sonography; and Marshall 
Hicks, a former MIR faculty 
member who is now head of 
interventional radiology at 
M.D. Anderson Cancer Cen- 
ter in Houston, Texas. 
Evens leads 
FPP Board 
In January, Ronald 
Evens, MD, director of 
Mallinckrodt Institute, was 
elected chairman of the 25- 
member Board of Directors 
of the Washington University 
School of Medicine Faculty 
Practice Plan (FPP). He suc- 
ceeds Ralph Dacey, MD, 
head of neurological surgery 
and the Board's first 
chairman. 
With more than 800 
physicians and clinical 
revenues of more than $250 
million, the full-time Wash- 
ington University School of 
Medicine (WUSM) physi- 
cians comprises one of the 
largest consolidated multi- 
specialty group practices in 
the United States. The FPP 
was initiated in 1997 to 
revamp clinical care at 
WUSM so that patients, 
referring physicians, and 
healthcare insurers would be 
better served. The Practice 
Plan Board is responsible for 
managing the medical 
school's clinical operations, 
with specific responsibility 
in the areas of clinical over- 
sight, administration, fiscal 
management, and clinical 
planning. 
"The establishment of 
the Washington University 
Faculty Practice Plan is a 
direct result of the rapidly 
changing healthcare mar- 
ket's effect on academic 
medicine nationwide and 
specifically in the St. Louis 
region," says Evens. "The 
FPP has already facilitated 
significant advances in 
strategic planning, medical 
management, and financial 
affairs, and we must con- 
tinue to provide initiatives 
that will efficiently re-engi- 
neer the way we practice 
medicine." 
Marilyn Siegel, profes- 
sor of radiology and of pedi- 
atrics, was elected to a 
second term on the Board 
as a faculty-at-large repre- 
sentative. From the more 
than 1,000 medical school 
faculty, six representatives 
are elected by full-time fac- 
ulty within the clinical 
departments. 
Siegel's first two years 
on the board were exciting 
and productive. "The FPP 
played an important leader- 
ship role in designing the 
new ambulatory care center, 
streamlining some patient 
care activities, and planning 
satellite facilities," she says. 
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w ▼   T ormen with advanced cervi- 
cal cancer can now look to 
chemotherapy to help fight their 
disease. Researchers have found 
that adding chemotherapy to the 
standard radiation therapy dramati- 
cally increases a woman's survival 
rate. Results from a series of five 
landmark studies, all sponsored by 
the National Cancer Institute dur- 
ing a seven-year period, are so sig- 
nificant that, for the first time in 
four decades, changes are being 
recommended in the treatment of 
cervical cancer. 
Results Li 
Radiation Oncologist Perry Grigsby 
Perry Grigsby, MD, MBA, 
FACR, professor of radiology at 
Mallinckrodt Institute, is a coau- 
thor of two reports documenting 
these study results; one of the 
reports was published in the April 
15th issue of The New England 
Journal of Medicine. Because of 
the potential impact on public 
health, the Journal released the 
study results on its web site prior 
to the slated publication date, and 
the NCI mailed a rare clinical 
announcement to thousands of 
physicians, notifying them of the 
findings and urging them to con- 
sider the combination of 
chemotherapy and radiation ther- 
apy for the treatment of invasive 
cervical cancer. 
The NCI recommends the com- 
bination treatment for women diag- 
nosed with advanced cervical 
cancer that has spread to the pelvic 
lymph nodes or to the parametrium 
(the connective tissue surrounding 
the uterus) and for those who have 
cancer cells in the tissues outside 
of the removed tumor. 
Radiation has been the treat- 
ment of choice for advanced cervi- 
cal cancer since the 1950s. While 
approximately 20 studies have 
been done outside of the United 
States using various combinations 
of radiation and the chemotherapy 
drugs hydroxyurea, cisplatin, and 
5-fluorouracil, none showed a ben- 
efit. The five studies in the United 
States, however, did show a benefit 
using cisplatin and 5-fluorouracil in 
tandem with radiation. 
Grigsby attributes the differ- 
ence in the study outcomes to the 
drugs selected and to the strict 
quality control guidelines of the 
U.S. research. The guidelines 
detailing the study are often 30 to 
40 pages in length. "The research 
that we do is conducted in a rigid, 
scientific manner. It's important 
research, and it's all done with tax- 
payers' dollars through the 
National Cancer Institute," Grigsby 
said. 
STUDY RESULTS 
Grigsby and scientists from the 
University of Texas M.D. Anderson 
Cancer Center, along with other 
institutions and universities, 
looked at the effects of adding 
chemotherapy to radiotherapy. The 
study included 403 women of all 
ages who had advanced cervical 
cancer with tumors that were too 
large to remove surgically or with 
cancer that had spread to pelvic 
lymph nodes. Patients were ran- 
domly assigned treatment methods: 
Some received external and inter- 
nal radiation, others received 
chemotherapy in addition to the 
internal and external radiation. 
For all patients, the radiation treat- 
ments were administered during an 
approximate six-week period. 
Externally, radiation was directed 
at the pelvic area. Internally, 
radioactive pellets were placed 
temporarily in the vagina and 
cervix. Those receiving chemother- 
apy had their first treatment within 
16 hours of the first radiation treat- 
ment, with two more cycles of 
chemo given at three-week inter- 
vals. The side effects were similar 
for the women in the two groups; 
however, women in the combined 
therapy group had a higher rate of 
blood-related problems, which 
were reversible. 
During treatment, patients 
were evaluated weekly. After treat- 
ment, evaluations were done every 
three months for the first two 
years. In the third year, evaluations 
were done every four months, then 
every six months during the fourth 
and fifth years. 
After five years, the survival 
rate for women receiving the com- 
bination of chemo and radiation 
was 73 percent. Those women who 
received only radiation had a 58 
percent survival rate. While these 
findings were encouraging, women 
in the combination therapy group 
could still have the disease. Taking 
the statistics a step further, 67 per- 
cent of the women who had 
received the combination treatment 
did not have cervical cancer after 
five years, while 40 percent of 
women in the radiotherapy group 
had beat the disease. 
Following the study, 
researchers found that adding 
chemotherapy reduced the chances 




New Studies Yield Results 
for recurrence of cervical cancer. 
This study also differed from oth- 
ers in that the median dose of radi- 
ation was higher and the median 
duration of treatment was shorter. 
A more aggressive regimen of 
chemotherapy was used with three 
cycles, administering a higher dose 
of cisplatin than the dose of fluo- 
rouracil used in other studies. 
Because of the poten- 
tial impact on public 
health, the Journal 
released the study 
results on its web site 
prior to the slated 
publication date... 
According to Grigsby, while 
the findings are significant, some 
women in the study were hesitant 
to undergo the chemotherapy. 
"Some patients said that if there 
was a chance she would receive 
chemotherapy, then she wouldn't 
participate in the study," he says. 
"They knew a relative or a friend 
who had undergone chemo and 
hadn't done well. Even though 
women knew that their survival 
rates might increase with the com- 
bined therapy, there was still some 
hesitancy." 
These volumetric images, produced from raw CT 
scans, reconstructed CT data, and digitally recon- 
structed radiographs, show axial, sagittal, and coro- 
nal views of the uterus, cervix, and tumor. Radiation 
oncology physicist Dr. Jeffrey Williamson received an 
NCI grant to study the treatment of locally advanced 
cervical cancer through an integration of imaging 
techniques. 
In a second study, chemother- 
apy and radiation were given to 
women with invasive cervical can- 
cer who had already undergone 
radical hysterectomies and lym- 
phadenectomies. In those cases, 
the cancer had spread to pelvic 
lymph nodes, to the tissue sur- 
rounding the tumor, or to the para- 
metrium. The survival rate for the 
268 patients participating was 63 
percent after four years. 
"The findings from this study 
[which were presented in March 
to the Society of Gynecologic 
Oncologists in San Francisco] 
also showed a significant benefit to 
adding chemotherapy to the radia- 
tion therapy," Grigsby says. 
The three remaining studies 
were similar in that radiation was 
compared with the chemotherapy 
drugs cisplatin, 5-fluorouracil, and 
hydroxyurea, and all of the studies 
found the addition of chemo to be 
beneficial. The studies were per- 
formed by three of the NCI's Clini- 
cal Trials Cooperative groups, 
comprised of institutions and 
physicians that conduct trials 
jointly. 
In these studies, chemotherapy 
and radiation were given simulta- 
neously—according to information 
from previous, smaller NCI studies, 
the treatments were found to have 
a greater effect when administered 
together than if given one after the 
other. Researchers believe that 
chemotherapy makes cells more 
receptive to radiation or vice versa 
Chemotherapy also may prevent 
cancer cells from repairing the 
damage caused by radiation. 
MALLINCKRODT INSTITUTE OF RADIOLOGY 



















CAUSE AND EFFECT 
Stopping the cancer cells 
becomes even more imperative 
when you look at the statistics: 
Cervical cancer is the most com- 
mon type of cancer in women 
worldwide. In 1998 in the United 
States, an estimated 13,700 women 
were diagnosed with invasive cervi- 
cal cancer. Of those, nearly 5,000 
will die from the disease. Accord- 
ing to the National Institutes of 
Health, half of the women with 
newly diagnosed invasive cervical 
cancer have never had a Pap test— 
the standard screening test for 
abnormalities. Another 10 percent 
have not had a Pap test in the past 
five years. Most at risk are minori- 
ties and low-income women who 
have insufficient access to and 
knowledge of the screening. The 
disease can be detected and treated 
early, with early detections tested 
and rated using a standardized 
scale. It is only after the disease 
has been undetected, often over 
the course of several years, that it 
becomes invasive. 
Pap tests are recommended 
when women become sexually 
active or at age 18. Generally the 
tests are done once a year, but if 
any abnormalities are detected, 
Pap tests are recommended more 
frequently. 
At the root of most cervical 
cancer—93 percent—lies the 
human papillomavirus, known as 
HPV. More than 70 types of HPV 
have been identified; twenty-three 
of them infect the cervix, accord- 
ing to information from the 
National Institutes of Health. Only 
some of them are associated with 
invasive cervical cancer. The virus 
is transmitted through sexual 
intercourse, and infection is most 
prevalent in women ages 22 to 25. 
Infection decreases with age, sug- 
gesting that most are resolved 
through host immune responses. 
"HPV is sexually transmitted, 
and it's clearly a cause of cervical 
cancer. But we don't know if all 
cervical cancers are caused by 
HPV," Grigsby says. 
In theory, cervical cancer can 
be prevented, and education is the 
key. Young women must learn 
how cervical cancer can be trans- 
mitted. Throughout their lifetime, 
women—and this includes post- 
menopausal women—must con- 
tinue to have regualr Pap tests. 
Worldwide research for an HPV 
vaccine has begun, and planning is 
underway at the NCI for a vaccine 
to be used as an auxiliary treat- 
ment after radiation or chemother- 
apy. Other vaccines focus on 
prevention. Early reports from an 
NCI study showed that a vaccine 
stimulated the body to produce 
antibodies to HPV. Further studies 
are being done, and if they are 
promising, the vaccine will be 
tested in larger numbers of 
women. ETJH 
Chris Wayland is a St. Louis- 
based free-lance writer. 
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BY KIRSTIN BLASE 
UALIZATION     OF     THE     COLON 
iolon cancer remains the second leading cause of cancer death in the 
United States, but a rapidly advancing technology may help to reduce that 
statistic through the early detection of colorectal polyps, the precursors of 
colon cancer. Spiral computed tomography (CT) colonography—or virtual 
colonoscopy—provides a noninvasive evaluation of the colon, using both 
two- and three-dimensional visualization displays. 
Elizabeth McFarland, MD, assistant professor of radiology at Mallinck- 
(Large background 
image) Two centimeter 
sigmoid polyp with 3-D 
endoscopic visualization 
with spiral CT. (This 
image is from Dr. 
McFarland's scientific 
paper "Evaluation of 
processing parameters 
with perspective volume 
rendering" published in 
a 1997 issue of the 
journal Radiology, vol- 
ume 205, pages 701- 
707.) 
rodt Institute, has received a $500,000 contract from the National Cancer 
Institute (NCI) to study the diagnostic performance of this evolving tech- 
nology. Along with the 3-D visualization of the entire colon, spiral CT 
colonography also views colorectal polyps from a variety of angles, using a 
spectrum of 2-D and 3-D image display techniques. 
This diagnostic breakthrough enables doctors to virtually maneuver 
through the colon by using a 3-D software package called Vitrea, which was 
Nine millimeter polyp in 
rectosigmoid (arrow) 
displayed with spiral CT, 
using 
(A) axial 2-D multipla- 
nar reformation (MPR) 
(B) sagittal 2-D MPR 
(C) 3-D endoscopic CT 
developed by Vital Images, Inc. of Minneapolis. With the patient's obvious 
benefit from a noninvasive procedure and the physician's diagnostic advan- 




Colorectal cancers are the third 
most frequently occurring can- 
cers among men and women in the 
United States. There are approxi- 
mately 160,000 new cases each year 
that result in 60,000 deaths and bil- 
lions of dollars in costs. At all ages, 
men are more likely to develop col- 
orectal cancer than women. African 
Americans have higher colorectal 
cancer incidence and mortality rates 
than men and women of other racial 
and ethnic groups. These staggering 
statistics reinforce the need for 
detection of early lesions and pre- 
cancerous polyps in the colon. 
"In the United States, there is a 
need for accurate, noninvasive, total 
colonic screening for colon cancer. 
Virtual colonoscopy may fill this 
need," says Leonard Weinstock, MD, 
a coinvestigator of the research and 
an associate professor of clinical 
medicine in the Division of Gas- 
troenterology. 
With virtual colonoscopy, the 
patient is positioned on the 
bed of a spiral CT scanner. After 
the bowel is prepped, air is intro- 
duced into the colon through a 
small tube. Operating on a slip-ring 
technology, spiral CT allows the bed 
on which the patient is lying to 
move through the gantry at a steady 
pace while the X-ray beam traces a 
360-degree spiral pathway around 
the patient. The patient is in the 
scanner for less than 30 minutes. 
Scans are taken—one while the 
patient is facedown; one, faceup— 
while the patient inhales, maintains 
a 40-second breathhold, and 
exhales. After the images are com- 
pleted, the air in the distended 
colon is removed through another 
small tube. Patients may experi- 
ence some minimal discomfort from 
cramping caused by the insufflation 
of air and distended colon. 
The CT images are then elec- 
tronically transferred to a dedicated 
3-D workstation. Using the Vitrea 
software, these images are con- 
verted into a three-dimensional vol- 
ume that is developed from 
approximately 200 CT slices, each 
about two millimeters thick. Multi- 
ple 3-D rendering algorithms are 
applied to automatically create a 
variety of interactive 2-D and 3-D 
visualizations. In general, a radiolo- 
gist can use the two-dimensional 
multiplanar reformations simultane- 
ously to cross-reference a focal find- 
ing in the axial, sagittal, and coronal 
planes. This provides not only a 
quick survey of the colon but the 
ability to interactively "fly" into the 
McFarland and the technical team in the Institute's Elec- 
tronic Radiology Laboratory (ERL): (left to right) Bruce 
Whiting, PhD; Thomas Pilgram, PhD; Barry Brunsden, 
research engineer; and Paul Koppel, PhD. Not shown is 
James Blaine, DSc, director of the ERL Whiting con- 
structed this phantom of a colon containing different 
sizes and shapes of polyps so the team could better 
study the rippling artifacts that can occur in spiral CT 
imaging. 
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3-D endoscopic view. The simulta- 
neously displayed intraluminal and 
extraluminal images also allow the 
radiologist to maintain orientation 
along the course of the colon. 
In early clinical trials, virtual 
colonoscopy has detected 67 to 83 
percent of polyps that are one cen- 
timeter or larger in size. In a multi- 
observer study to assess the 
diagnostic performance of spiral CT 
I id to evaluate the radiologists' 
terpretations, doctors Jay Heiken, 
,  ofessor of radiology and codirec- 
- of body computed tomography; 
nnis Balfe, professor of radiol- 
*y; and James Brink, vice-chair- 
lan of the Department of 
Jadiology at Yale University, com- 
pared results from a spiral CT test 
set of colonic segments to those 
achieved with colonoscopy, the 
gold standard for detecting colorec- 
tal polyps. With both 2-D and 3-D 
display techniques, CT's overall sen- 
sitivity to detect polyps ranged from 
83 to 92 percent. Heiken, Balfe, and 
Brink also reread the cases in a sec- 
ond session, and both intra- and 
inter-observer agreement were very 
good. MIR investigators also are 
collaborating with Ge Wang, PhD, 
of the University of Iowa, on a new 
display technique to "unravel" the 
colon. 
Multiple issues of the rapid spiral 
CT acquisition are under inves- 
tigation, including the occurrence 
of rippling artifacts that can 
degrade the image quality. Bruce 
Whiting, PhD, of the Institute's Elec- 
tronic Radiology Laboratory, devel- 
oped specific quantitative metrics 
to evaluate the influences of CT 
acqusition parameters, such as 
pitch and angle, on the frequency 
and magnitude of the artifact. This 
approach is being used to analyze 
the performance of a new genera- 
tion of multirow detector CT scan- 
The clinical team: Clinical coordinator Mary Virginia 
Gaines; Leonard Weinstock, MD, (left); and Jay Heiken, 
MD. Not shown is Benjamin Littenburg, MD. 
ners. "With this approach, a better 
understanding of the image forma- 
tion process will result in improved 
diagnostic information," says 
Whiting. 
Systems costs is a major con- 
sideration in the acceptance of vir- 
tual colonoscopy by the general 
community. In the early phases of 
the studies, the UNIX-based sys- 
tems for the silicon graphics-level 
computers cost arround $200,000. 
Currently, a UNIX-based system 
called 02 is considerably less 
expensive at approximately $20,000. 
"The competitive pressures are 
such that all vendors, all different 
software companies, are pushing 
this into an NT environment, a 
desktop environment," says McFar- 
land. "The computer graphics that 
enable this type of visualization are 
pushed by a demand for three- 
dimensional visualization. Further 
competition will make this worksta- 
tion more affordable in coming 
years." 
Spiral CT colonography, as is true 
of most new medical procedures, 
will go through varying stages of 
development. The study is now in 
the second stage of technology 
assessment: the evaluation of 
reader performance among expert 
readers compared to conventional 
colonoscopy performance. Follow- 
ing optimization and standardiza- 
tion of numerous parameters of 
both image acquisition and render- 
ing, performance of this technique 
among expert radiologists first 
needs to be determined. The diag- 
nostic performance of spiral CT in 
generalized settings will then be the 
next stage. 
The Mallinckrodt Institute con- 
tract is part of a larger Washington 
University grant coordinated by 
Principal Investigator Gerald Andri- 
ole, MD, who is head of a preven- 
tive cancer research organization 
called PLCO (an acronym for 
prostate, lung, colon, and ovary). 
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Currently, McFarland's study is 
recruiting 70 patients with colorec- 
tal polyps who also meet the crite- 
ria of Andriole's PLCO study. At 
this point, the CT exam is in the 
validation stages and is not avail- 
In early clinical trials, 
virtual colonoscopy 
has detected 67 to 83 
percent of polyps that 
are one centimeter or 
larger in size. 
able as a routine test. If results 
continue to be promising, the next 
stage will be technology assess- 
ment of spiral CT in the general 
community. 
Virtual colonoscopy is defi- 
nitely a product of a constantly 
expanding computer age. The tran- 
sition of two-dimensional CT slices 
into a three-dimensional image of 
the colon has entailed a multitude 
of expertise. As McFarland points 
out, "This technology will require a 
very strong multidisciplinary coop- 
erative effort where radiology, gas- 
troenterology, computer science, 
and electrical engineering work 
very closely together." 
With decreasing workstation 
costs and additional applications 
for the procedure, such as the tra- 
chea, the possibilities of this tech- 
nology reaching the general 
community is increasing. It's virtu- 
ally there, cm 
Editor's note: Dr. McFarland's spiral 
CT colonography research has also 
been generously funded by a two-year, 
General Electric-Association of Uni- 
versity Radiologists career grant and 
by grants from the Barnes-Jewish 
Hospital and Washington University 
Cancer Center. 
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RISK FACTORS FOR COLORECTAL CANCER 
I Age—Older age is the single most important risk fac- 
tor for the development of colorectal cancer. 
i Familial factors—A personal history of colon can- 
cer, intestinal adenomatous polyps, or inflammatory 
bowel disease also increase a person's likelihood of 
developing colorectal cancer. 
i Diet—A diet high in animal fats(i.e., red meats) is 
thought to increase the risk for developing colorectal 
cancer while a diet high in vegetables and fruits is 
considered protective. 
Physical activity—Participation in regular physical 
activity may reduce a person's risk for developing 
colon cancer. Obesity has been shown to increase the 
risk for colon cancer in men. 
Hormone replacement therapy—Current use of 
hormone replacement therapy may decrease the risk 
for developing colorectal cancer in postmenopausal 
women. 
Aspirin use—Men and women who use nonsteroidal 
anti-inflammatory drugs may have a decreased risk for 
developing colon cancer and other cancers of the 
digestive tract. 
This information was excerpted from the American Cancer Society's 1999 
Facts & Figures. 
VIRTUAL COLONOSCOPY 
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UTERINE ARTERY EMBOLIZ ATION:    AN ALTERNATIVE TO  HYSTERECTOMY 
Tyi-any women with uterine fibroids have discovered a third treatment option: a relatively new 
lVlnonsurgical procedure called uterine artery embolization. The concept was develonedTn 
France in the ear y 1990s and has been adopted worldwide for the treatmento7more IhaTl OoS 
women with excellent clinical and therapeutic results. In the United States, it Sperfo^edZtindy 
at an mcreasing number of medical facilities, including Washington University MedicXnter 
t      £ ? * 1^       m°St common benign tumors in women in the United States todav ' From 
lZT°'TPeTnt °f W°men ^ flbr°idS "*> aMrou«h 0^y a ^* °f the tumorsSe wZ tomato, millions of women continue to live with them because the only alternative is surgery  X 
me artery embolization has the potential to transform how fibroids are treated ^SS'rkm* 
Institute of Radiology's David Hovsepian, MD, assistant professor of ZSo^L Xr^*"* 
gist a^d VaS:^Rafts'anH Th" ^--doctors S—* Vedantham, af interventionafradiolo- gist, and Valerie Ratts and Thomas Herzog, gynecologists—founded the Washington Universitv 
Comprehensive Fibroid Center to treat women with this common problem b^SZg exceUent 
care and acquainting them with all of their treatment options Providing excellent 
Since June 1998, Hovsepian himself has treated seven women with uterine artery embolizatinr, 
and has more cases scheduled. Several women have found him via the IntemetTJr^TabZ 
soSc^r m magaZin6S °r neWSPaPerS'  H°VSepian 1S impressed b^ httatients^eS 
"These women are highly motivated and well-educated," he says. "They have usually been told 
SE^SST^' S° ^ * ^ ** ^ d° — -eLive hoTetoil^nd 
PROCEDURAL BACKGROUND 
Uterine fibroids-or leiomyomata-are benign growths that arise from the muscular wall of the 
uterus. In some women, they can cause excessive menstrual bleeding, pain, LTa fee^of heavt 
ness in the abdomen. In fact, they may 
grow so large that a woman appears to be 
in an advanced state of pregnancy. 
Fibroids also may exert pressure on the 
bladder and lead to voiding problems and 
even incontinence. 
Traditionally, a hysterectomy has been 
the recommended treatment, particularly 
for older women who are not concerned 
about preserving their fertility. In 1995, for 
example, some 600,000 women under- 
went a hysterectomy, making it the most 
commonly performed surgical procedure 
in women in the U.S. One-third of those 
procedures was for the treatment of uter- 
ine fibroids. 
Myomectomy, which spares the 
uterus, is an alternative to hysterectomy, 
especially for younger women who may 
later wish to become pregnant. It is a 
more time-consuming procedure than a 
standard hysterectomy, even longer if the 
procedure is done laparoscopically, since 
the physicians painstakingly remove the 
Intervention^ Radiologist David Hovsepian 
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The cluster of two small circles and one square on each of the three images represents a dosimetry badge that monitors the amount of radiation. 
1. Pre-embolization arteriogram shows prominent left and right uterine arteries (arrows) due to high blood flow. 2. Selective injection of left 
uterine artery shows a large fibroid (area within arrows). 3. Postembolization arteriogram shows no filling of uterine artery, but all other pelvic 
branches have normal blood flow. The dense area is the bladder (arrow), which has filled with contrast from the procedure. 
individual fibroids. Not only does myomectomy carry the risks of any surgical procedure, there 
are other disadvantages as well: Small fibroids may be left behind only to enlarge later, or brand 
new fibroids may grow. Most frustrating of all is the chance that the key fibroid, which is causing 
most of the problems, may be left untreated. 
In the early 1990s, a French physician, Jacques Ravina, conducted a study of women awaiting 
myomectomies. To reduce blood loss during surgery, Ravina and his colleagues embolized the 
patients' fibroids preoperatively. The results were surprising. The fibroids shrank, and the bleed- 
ing stopped. Many women were so pleased with the results that they canceled their planned 
surgery. To verify these findings, the investigators conducted a multicenter trial and had the same 
results. 
Physicians at the University of California, Los Angeles (UCLA) learned of the French group's 
published reports and, in 1996, began their own study of uterine artery embolization. In the initial 
experience at UCLA, 11 women who had failed medical or surgical therapy underwent emboliza- 
tion. Out of nine women who completed the postoperative questionnaire, eight experienced 
symptomatic relief; only the ninth woman required a hysterectomy because of an infection. Thus, 
the technical success and the symptomatic improvement rate were very high. 
When Hovsepian saw a presentation of the UCLA data, he was fascinated by this procedure, a 
fascination fed by his clinical interest in gynecologic interventional radiology—especially methods 
for treating fallopian tube occlusion and possible ways to achieve reversible tubal sterilization— 
and for treating pelvic venous congestion syndrome, a poorly understood and underrecognized 
condition in women who suffer from debilitating pelvic pain and pressure. 
"In truth, uterine artery embolization is not a new technology. It is a new application of exist- 
ing techniques," he says. "For years, many women have only been given the option of a hysterec- 
tomy for treatment of their fibroids, which has meant the loss of being able to bear children. 
Embolization for fibroids has the potential for helping a lot of women." 
THE MIR TECHNIQUE 
If a patient refers herself to Hovsepian and has not been seen recently by a gynecologist, Hov- 
sepian first refers her to the gynecologists on his team for a physical exam and lab tests to rule out 
other reasons for her symptoms and to discuss the surgical options. Those patients who are still 
interested in having the embolization then meet with Hovsepian and clinical coordinator Pat Nor- 
ton, RN, to discuss what the patient should expect before, during, and after the procedure. 
On the day of the embolization, the patient checks in to the hospital early in the morning to 
undergo any remaining tests. She is instructed not to eat any food after midnight preceding the 
morning of the embolization. The procedure requires intravenous sedation only, not general anes- 
thesia, so the recovery period is short and without side effects. 
XALSPOT, SPRING, 1999 15 
UTERINE ARTERY EMBOLIZATION:    AN ALTERNATIVE  TO  HYSTERECTOMY 
The secret to the success of embolization, says Hovsepian, is that fibroids are highly vascular 
and dependent on blood supplied by the left and right uterine arteries. In the arteriogram, taken at 
the beginning of each procedure, these arteries are very visible. Engorged with blood, they become 
enlarged and take an easily recognizable course to the uterus. 
The objective of the procedure, which can take from one to three hours, is to block the blood 
flow through these arteries. It is necessary to embolize both arteries, Hovsepian stresses. Previous 
experience in which only one artery was blocked resulted in failure. 
Through a small incision in the patient's groin, physicians insert a tiny plastic tube, or catheter, 
which is guided into each uterine artery—one after the other—using the arteriogram as a map. 
Once the catheter is in place, 350 to 500 micron-size particles of polyvinyl alcohol (the size of grains 
of sand) are injected through the catheter. These granules immediatley block the arteries, obstruct- 
ing blood flow to the fibroids. 
"In most of these cases, as soon as the fibroids have been embolized, the patient feels crampy 
abdominal pain, sometimes accompanied by nausea and vomiting—called 'post-embolization syn- 
drome'—that lessens over the next few days," says Hovsepian. "It is usually necessary for the 
patient to stay overnight in the hospital so that she can be given strong medicines to provide opti- 
mum pain control." 
During the procedure, the patient receives intravenous medication for pain and relaxation; 
afterwards, she is placed on a morphine patient-controlled analgesia (PCA) pump, so that she can 
determine her own need for pain relief. Gradually, the patient is switched to oral medicines. 
Ibuprofen and Tylenol® are also added to treat the soreness and fever that usually develop during 
the first few days after embolization as the fibroids begin to break down. By the third or fourth day 
after the procedure, the patient can usually return to a modified routine, with most women return- 
ing to work within a week. 
All of the fibroids are treated at the same time, and as they have been starved for oxygen or 
nutrients, they begin to shrink. Some fibroids "melt" away entirely, and occasionally some which 
have grown on a stalk inside the uterine cavity may even be expelled. A follow-up ultrasound at six 
months shows that, on average, the fibroids have diminished in size by 40 to 50 percent. 
"If you combine all of the available reports," says Hovsepian, "approximately ninety-two per- 
cent of patients have sufficient symptomatic relief from either pain or bleeding so that no further 
treatment is necessary." 
A fter undergoing uterine artery embolization, a few women in their forties stopped having 
X\periods. It is still unclear whether or not embolization effected the early onset of menopause 
for these women or whether they were already perimenopausal, a fact which became evident only 
after the abnormal bleeding had disappeared. 
Therefore, until embolization's possible effect on fertility is determined, younger women who 
want to have children are being counseled to consider myomectomy, unless it is not feasible, 
instead of embolization. No negative impact from embolization has been found. In fact, in a group 
of 25 women who had uterine artery embolization for postpartum hemorrhage, each of the six 
patients who tried to become pregnant afterwards succeeded. 
"We explain all of this in detail to patients before the procedure so that they can understand the 
potential risks and benefits and can make their own informed decisions," Hovsepian adds. 
Hovsepian and his colleagues have constructed a database to track information on patients, 
their risk factors, fibroids, and ultrasound findings. A multicenter trial is in the planning stages to 
thoroughly evaluate the results of this procedure and to compare it with the current gold standard, 
myomectomy. There are a number of questions that remain unanswered, such as who will and who 
won't benefit from this procedure, but for now, he says, "Uterine artery embolization has the poten- 
tial for helping a large number of women." 
Editor's note: For more information, visit the Comprehensive Fibroid Center's web site at 
www.mir.wustLedii/fibroid. 
t-  ' 
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ONE   WOMAN'S   CRUSADE 
Gail Hudson's uterine artery embolization was the most difficult—and longest—of any per- 
formed by interventional radiologist David Hovsepian.   But Hudson, a St. Louis resident, is 
still an ardent fan. In fact, Hovsepian calls her a "one-woman crusade" for the procedure. 
In a routine examination some 15 years ago, Hudson's physician found a fibroid mass the size 
of a grape. Over the years the mass grew much larger, finally to the size of a cantaloupe. But Hud- 
son didn't have many symptoms, except heavier than normal menstrual periods and an increasingly 
distended abdomen. 
"Then I started to get indigestion and heartburn," she says. "The bulk of the growth had begun 
to push up over my navel. That's when I decided that I had been 'pregnant' with this long enough." 
After she read a short piece in a magazine about uterine artery embolization, Hudson, a soft- 
ware systems engineer, went to the Internet to learn everything she could about the procedure. 
Impressed by what she found, Hudson decided to undergo the embolization—but where? At first, 
she considered flying to Los Angeles where doctors were performing the procedure, but then she 
found Hovsepian's name on the Internet and decided she could get the same treatment much closer 
to home. 
In October 1998, Hudson had the procedure, which took longer than usual—a full three hours. 
After surgery, she seemed to have bypassed the typical crampy pain; two days later it hit, with pain, 
dizziness, and vomiting. Gradually, Hudson felt better and two weeks later went back to work. 
Now her uterine mass is down to the size of a tennis ball, and the abnormal bleeding has stopped. 
Hudson was pleased with the "awesome" care she received from Hovsepian, who was compas- 
sionate and concerned throughout her treatment. She was so delighted with the results of the pro- 
cedure that she wants to let other women know about it and has even invited Hovsepian to speak to 
a group of her coworkers about the procedure. 
"It seems as though everyone you talk to knows someone with fibroids or is in the situation 
herself.   Hopefully, we will get the word out to them that there is an alternative to surgery," she 
says, ima 
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"^here's a fine line between art and 
science, and that connection is 
especially apparent in a research 
project of radiologists Douglas Robertson 
and William Totty and senior research 
engineer Kirk Smith. Using their expertise 
in computed tomography (CT) and rapid 
prototyping technology, the Mallinckrodt 
Institute team is collaborating with The 
Saint Louis Art Museum in the restoration 
of an ancient Egyptian mummy mask. 
The funerary mask, which may have 
belonged to a noblewoman who lived 
around 1250 BC, during the time of Ram- 
ses the Great, provides a rare opportu- 
nity to research materials and artists' 
techniques used during the height of 
Egypt's artistic achievements. Due to the 
mask's fragility, the Art Museum conser- 
vators needed a means to objectively 
study the damaged areas of the mask and 
plan the repairs without causing additional 
harm to the artifact. 
For the past three years, Robertson, 
an assistant professor of radiology and of 
orthopaedic surgery, has been studying a 
new rapid prototyping technology that 
uses patient data gathered from computed 
tomography or magnetic resonance imag- 
ing to create detailed copies of the 
patient's anatomy. Funded in part by a 
Whitaker Biomedical Foundation grant and 
working with Stratasys, Inc., the Min- 
nesota-based company who developed the 
rapid prototyping software, Robertson is 
evaluating the technology for its use in 
producing three-dimensional models to aid 
in the preplanning of hip joint replacement 
surgery. 
**V A 
I. Conservator Suzanne Hargrove shows William 
Totty, MD, (leit) and Douglas Robertson, MD, PhD, 
the progress on repair of the diadem and portions of 
the hair. 
2. The model, made of layers of nontoxic wax or 
plastic, replicates the damaged areas of the original 
mask, which was formed by layers of thin linen, plas- 
ter, and wood. 
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Robertson is eager to test other 
applications for the rapid prototyping 
equipment, and the museum project pro- 
vided a rare opportunity. Because the 
mask has no water content and is compa- 
rable in value to bone, Totty, who is a 
professor of radiology specializing in mus- 
culoskeletal imaging, used computed 
tomography (CT) to produce images com- 
prised of 500 slices, each one millimeter 
thick. Working after hours so there would 
be no disruption in the scheduling of 
patients, the research team then converted 
the CT data to computer-aided design 
(CAD) descriptions that would be chan- 
neled to computer-controlled modeling 
equipment. 
A large hole on the top portion of the 
mask's head required extensive repair. In 
order to protect the mask from excessive 
handling, the actual repairs were to be 
made on a one-to-one ratio model. The 
repair would then be lifted from the model 
and placed directly onto the corresponding 
^^■^^ 
3 & 4. Suzanne Hargrove (above with Dr. Totty and 
below with Kirk Smith) is attempting to match the 
damaged bitumen hair or wig portions of the mask. 
Bitumen is a hydrocarbon, such as asphalt or tar, 
that was used in ancient Asia Minor as a cement or 
mortar and as a waterproofing agent. 
(Round inset, interior view) The model identifies 
cracks and weakened portions of the actual mask. 
^ 
«*-« 




area of the mask. The rapid prototyping 
equipment housed in Mallinckrodt Insti- 
tute's Musculoskeleta! Modeling and Visu- 
alization Laboratory is limited to a 10-inch 
cubic volume and could not replicate the 
mask's approximately 21-inch size.  So 
the CAD data was transmitted to Strata- 
sys' headquarters, where commercial 
modeling equipment has been used to pro- 
duce models as large as car engines used 
in automobile industry research. 
The resulting mask model was a 
resounding success. "We were pleased 
that the full-scale model picked up so much 
detail and were excited to be a part of 
this important project," says Robertson. 
"The link between human history and sci- 
entific technology is invaluable for all gen- 
erations." 
Back at the museum, objects conser- 
vator Suzanne Hargrove is using the 
model twin to meticulously reconstruct the 
original mask's damaged areas. The 
restored mask is scheduled to be part of a 
mask exhibit at The Art Museum this fall. ™» 
5. The face was originally fashioned from a gold foil, 
which has oxidized over the years to a deep red 
color. Gold on the face of a burial mask was 
reserved for high-ranking individuals. The eyes, eye- 
brow, and eyeliner are made of inlaid glass, which at 
the time was considered as valuable as gems. 
6. The diadem encircling the top portion of the head 
is highlighted with gilding and is comprised of glass 
inlays. 
(Round inset) The scene on the bottom chest portion 
of the mask depicts the deceased's entrance into the 
afterlife where she is met by Osiris, god of the 
underworld. 
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or staff or who have an appointment in the Department of 





Joseph Borrello, MD, 
assistant professor of radiol- 
ogy, Division of Diagnostic 
Radiology, has accepted a 
position with Kalamazoo 
Radiology, P.C., in Kalama- 
zoo, Michigan. 
Andrew Fisher, MD, assis- 
tant professor of radiology, 
Division of Diagnostic Radi- 
ology, has accepted a posi- 
tion with Radiology Imaging 
Associates in Englewood, 
Colorado. 
Lorraine Portelance, MD, 
instructor in radiology, Radi- 
ation Oncology Center, com- 
pleted a one-year fellowship 
in radiation oncology and 
has accepted a position with 
the Work Centre Hospitalier 
Regional de l'Outaouais in 
Gatineau, Quebec, Canada. 
Rao Vallabhaneni, PhD, 
instructor in radiology, 
Division of Radiological 
Sciences. 
Myeong Yoon, MD, instruc- 
tor in radiology, completed 
four years of training in diag- 
nostic radiology and a six- 
month fellowship in breast 
imaging. She has accepted a 
position with Radiology 




Jay Heiken, MD, professor 
of radiology, chief of abdom- 
inal radiology, and codirec- 
tor of body computed 
tomography, was selected as 
the 1999 Traveling Fellow of 
the Society of Gastrointesti- 
nal Radiologists. 
Clifford Chao, MD, assis- 
tant professor of radiology, 
as principal investigator, 
received a one-year Barnes- 
Jewish Hospital Cancer 
Research Award to study 
"The impact of tumor 
hypoxia/reoxygenation 
kinetics on radiation curabil- 
ity in head and neck can- 
cers." Coinvestigators for 
the $30,000 grant are Walter 
Bosch, DSc, instructor in 
radiology; Duffy Cutler, 
PhD, assistant professor of 
radiology; Farrokh 
Dehdashti, MD, associate 
professor of radiology; 
Barry Siegel, MD, profes- 
sor of radiology and of medi- 
cine and director of the 
Division of Nuclear Medi- 
cine; and Michael Welch, 
PhD, professor of radiology 
and of chemistry and codi- 
rector of the Division of 
Radiological Sciences. 
Thomas Conturo, MD, 
PhD, assistant professor of 
radiology and adjunct assis- 
tant professor of physics, as 
principal investigator, 
received a National Insti- 
tutes of Health/National 
Institute of Neurological Dis- 
orders and Stroke grant in 
the amount of $2,024,851 for 
research on "MR perfusion 
imaging for functional brain 
studies." Coinvestigators for 
the five-year grant are Erbil 
Akbudak, PhD, research 
instructor in radiology; 
Joanne Markham, MS, 
research associate, Institute 
of Biomedical Computing, 
and research assistant pro- 
fessor of medicine, Washing- 
ton University; Abraham 
Snyder, PhD, MD, research 
scientist of radiology; and 
Mark Mintun, MD, associ- 
ate professor of radiology. 
Elizabeth McFarland, MD, 
assistant professor of radiol- 
ogy, as principal investiga- 
tor, received a two-year 
March of Dimes Birth 
Defects Foundation grant for I 
research on "MRI evaluation 
of soft palate motion during 
speech: comparison between | 
cleft palate patients." Peter 
Witt, MD, assistant professor | 
of surgery (plastic and 
reconstructive), Washington 
University, is coinvestigator 
for the $87,000 grant. 
Joseph Roti Roti, PhD, 
professor of radiology, asso- 
ciate director of the Radia- 
tion Oncology Center, and 
chief of cancer biology, as 
principal investigator, 
received a one-year renewal 
grant from the National 
Institutes of Health for 
research on "Nuclear-protein 
content and heat-induced 
ceh killing." Coinvestigator 
for the $223,585 grant, now 
in its thirteenth year, is 
Ryuji Higashikubo, PhD, 
research assistant professor 
of radiology. 
Weili Lin, PhD, assistant 
professor of radiology, as 
principal investigator, 
received a $1.2 million giant 
from the National Institutes 
of Health/National Instil ute 
of Neurological Disorders 
and Stroke for the stud\ of 
"Quantitative brain oxiiuetry 
using MRI." Coinvestigators j 
for the four-year grant are 
Mark Haacke, PhD, profes | 
sor of radiology and of elec- 
trical engineering and 
director of the magnetic res- 
onance imaging researc 
laboratory; William Po^ - 
ers, MD, associate profes- 
sor of neurology and 
neurological surgery an   if 
radiology; and Chung H 
MD, professor of neurol   ■>'. 




Jeffrey Bradley, MD, 
„.structor in radiology, was 
appointed associate director 
of clinical curriculum for the 
Radiation Oncology Center 
Residency Training Program 
at Mallinckrodt Institute. 
Jay Heiken, MD, professor 
Df radiology, chief of abdom- 
nal radiology, and codirec- 
• of body computed 
tomography, was appointed 
i the 1999 Radiological 
Society of North America 
I Scientific Assembly and 
Annual Meeting Program 
Committee, Gastrointestinal 
Subcommittee. 
Jeff Michalski, MD, assis- 
nt professor of radiology, 
vas appointed to associate 
Imembership in the Tnter- 
I group Rhabdomyosarcoma 
I Study Group, an affiliate of 
the Children's Cancer Group 
and Pediatric Oncology 
jroup. 
Scott Mirowitz, MD, asso- 
ciate professor of radiology, 
radiologist-in-chief at 
: Barnes-Jewish Hospital 
north, and codirector of 
body magnetic resonance 
imaging, was named a Diplo- 
mate of the American Col- 
lege of Physician Executives. 
He was appointed to the 
American Roentgen Ray 
Society's (ARRS) Instruc- 
tional Committee as coordi- 
nator of the Socioeconomic 
Track for ARRS' 2000 Annual 
Meeting. 
Joseph Roti Roti, PhD, 
professor of radiology, asso- 
ciate director of the Radia- 
tion Oncology Center, and 
chief of cancer biology, was 
appointed to a one-year term 
as councillor of the North 
American Hyperthermia 
Society and was appointed 
to the International Organiz- 
ing Committee of the Cell 
Stress Society. 
Barry Siegel, MD, profes- 
sor of radiology and of medi- 
cine and director of the 
Division of Nuclear Medi- 
cine, was appointed chair- 
man of the Diagnostic 
Radiology Committee of the 
American College of Sur- 
geons Oncology Group. 
Pamela Woodard, MD, 
assistant professor of radiol- 
ogy, was appointed to the 
editorial board of Current 
Protocols in MRI, a quarterly 
reference guide. Mark 
Haacke, PhD, professor of 
radiology and of electrical 
engineering and director of 
the magnetic resonance 
imaging research laboratory, 
is editor, and Weili Lin, 
PhD, assistant professor of 
radiology, is associate editor. 
Senturia Lecture 
Thomas Spackman, MD, chairman of Xicon Tech- 
nologies and former president and CEO of Elscint, 
Inc., presented the Fifth Annual Hyman R. Senturia 
Lecture on February 8 in MIR's Scarpellino Audito- 
rium. Dr. Spackman, who also is a clinical professor 
of radiology at the University of Connecticut, spoke 
on "Watching radiology by an occasional radiologist." 




DeWitte Cross, MD, assis- 
tant professor of radiology, 
as invited lecturer, pre- 
sented a seminar on "Man- 
agement of posterior 
circulation aneurysms" and 
"Clinical response to intra- 
arterial papaverine for cere- 
bral vasoplasm" at the 
American Association of 
Neurological Surgeons and 
Congress of Neurological 
Surgeons Joint Section on 
Cerebrovascular Disease 
and American Society of 
Interventional and Thera- 
peutic Neuroradiology Meet- 
ing, Nashville, Tennessee, 
January 31 - February 3. 
Duffy Cutler, PhD, assis- 
tant professor of radiology, 
as invited lecturer, spoke on 
"Whole body PET: 2D or 
3D?" at the Society of 
Nuclear Medicine Mid-Win- 
ter Symposium, Fort Laud- 
erdale, Florida, February 8 
and 9. 
Colin Derdeyn, MD, assis- 
tant professor of radiology, 
presented "A cost-effective 
analysis of therapy for symp- 
tomatic carotid occlusion: 
PET screening followed by 
selective EC/IC bypass ver- 
sus medical treatment" and 
"Benign course of asympto- 
matic carotid occlusion" at 
the 24th International Joint 
Conference on Stroke and 
Cerebral Circulation, 
Nashville, Tennessee, Febru- 
ary 4. He spoke on "Carotid 
disease and stroke" and 
"Acute stroke intervention" 
at the Current Concepts in 
Peripheral Vascular Disease 
Symposium, NorthEast Med- 
ical Center, Concord, North 
Carolina, February 16. 
David Diamond, MD, assis- 
tant in radiology and cochief 
resident, Radiation Oncol- 
ogy Center, presented "Vas- 
cular radiotherapy for 
restenosis" at the Society of 
Cardiovascular and Inter- 
ventional Radiology, 
Orlando, Florida, March 14. 
Lawler receives BJH award 
Leo Lawler, MD, a third-year diagnostic radiology resi- 
dent, received the Barnes-Jewish Hospital Founda- 
tion's Caring Spirit Award, which honors individuals 
for their care, compassion, and service above and 
beyond expectation. Lawler was nominated for the 
award for his "beyond the typical" care and concern 
for his patients as well as for his professionalism. The 
mother of one patient cited that Lawler visited her son 
morning and evening without fail and that after her 
son's release from the hospital, "Doctor Lawler called 
two to three times per week to just check in and see 
how things were going." 
Keith Fischer, MD, associ- 
ate professor of radiology, 
spoke on "Labeled antibod- 
ies: emphasis on prostate 
cancer imaging" and "Tumor 
imaging with Ir-111 labeled 
somatostatin analogs" at the 
Mississippi Society of 
Nuclear Medicine's "Nuclear 
Medicine Update," Jackson, 
Mississippi, March 13 and 
14. 
Perry Grigsby, MD, MBA, 
professor of radiology, as a 
member of the American 
Cancer Society's Traveling 
Oncology Consultant Pro- 
gram, spoke on "Manage- 
ment of carcinoma of the 
cervix," "Management of car- 
cinoma of the endometrium," 
"NIH Consensus Conference 
on carcinoma of the cervix," 
and "Management of carci- 
noma of the thyroid" at med- 
ical facilities in Van Nuys, 
Long Beach, Los Angeles, 
Burbank, Santa Monica, 
Tarzana, and Loma Linda, 
California, February 8 -12. 
He presented "FDG-PET 
evaluation of primary carci- 
noma of the cervix" at the 
30th Annual Meeting of the 
Society of Gynecologic 
Oncologists, San Francisco, 
California, March 20 - 24. 
Robert Gropler, MD, asso- 
ciate professor of radiology  i 
and director of the cardio- 
vascular imaging laboratory, 
presented "Impairment of 
myocardial blood flow alters 
the myocardial stress-strain 
relations in ischemic car- 
diomyopathy" at the Ameri- 
can College of Cardiology 
48th Annual Scientific Meet-  ] 
ing, New Orleans, Louisiana,  J 
March 7 -10. 
Jay Heiken, MD, professor 
of radiology, chief of abdom- 
inal radiology, and codirec- 
tor of body computed 
tomography, presented 
"Hepatic contrast enhance- 
ment: a pharmacokinetic 
approach" and "Contrast 
enhancement for helical CT 
of the liver and pancreas: 
lessons and solutions from 
computer modeling" at the 
International Symposium: 
Abdominal Imaging 1999, 
Kumamoto, Japan, January 
22 and 23. He presented the 
Special Lecture, "CT evalua- 
tion of nontraumatic emer- 
gencies of the gastro- 
intestinal tract," at the 
Annual Meeting of the 
Kyushu Society of Interven- 
tional Radiology, Kumamoto. 
Japan, January 23. As visit- 
ing professor, Heiken spoke 
on "A pharmacokinetic 
approach to hepatic and 
pancreatic enhancement for 
helical CT: lessons from 
computer modeling" at 
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'okohama City University, 
'okohama, Japan, January 
26. He spoke on "A practical 
approach to helical CT," "CT 
^of the aorta: approach to 
ipture and dissection," 
Characterization of hepatic 
passes with CT and MRI," 
Ind "CT evaluation of non- 
traumatic GI emergencies" 
at Sun Valley Imaging, spon- 
sored by the University of 
British Columbia, Sun Val- 
ley, Idaho, February 20 - 27. 
[e presented "Imaging of 
ie acute abdomen: abdomi- 
nal aortic aneurysm" at the 
Twenty-Eighth Annual Meet- 
ig and Postgraduate Course 
[of the Society of Gastroin- 
;estinal Radiologists, Palm 
leach, Florida, March 21 - 
26. 
Eric Klein, MS, assistant 
irofessor of radiology, as 
vited lecturer, spoke on 
"Multi-segmented electron 
IMRT fields" at the Intensity 
Modulated Electron Radio- 
itherapy Symposium, Palo 
fAlto, California, March 22. 
William McAlister, MD, 
professor of radiology and 
of pediatrics and chief of 
pediatric radiology, as 
invited lecturer, presented 
"Alimentary tract emergen- 
cies in children" at the 
Armand Brodeur Lecture, 
sponsored by the City-Wide 
Radiology Conferences, 
Saint Louis University, St. 
Louis, Missouri, January 12. 
As invited lecturer, he pre- 
sented "Imaging of sinusitis 
in pediatrics" at the Larry 
Davis Memorial Lecture, 
Rosair Children's Hospital, 
Louisville, Kentucky, Febru- 
12. 
Elizabeth McFarland, MD, 
assistant professor of radiol- 
ogy, presented "3D spiral CT 
endoscopic applications" to 
the St. Louis Society of Radi- 
ologists, St. Louis, Missouri, 
January 19. She presented 
"Spiral CT colonography: 
technical considerations of 
image acquisition and image 
display" at the General Elec- 
tric-Association of Univer- 
sity Radiologists Research 
Symposium, San Diego, Cali- 
fornia, March 12. 
Robert McKinstry, MD, 
PhD, instructor in radiology, 
as invited lecturer, spoke on 
"Diffusion tensor imaging" at 
the University of Illinois, 
Chicago Medical Center, 
Department of Radiology, 
January 20. 
Jeff Michalski, MD, assis- 
tant professor of radiology, 
presented "Radiation in 
brain tumors" at the Brain 
Tumor Support Network 
meeting, sponsored by Mis- 
souri Baptist Medical Cen- 
ter, St. Louis, Missouri, 
February 9. He spoke on 
"3D CRT in prostate carci- 
noma," "Quality assurance 
for 3D CRT clinical trials," 
and "3D conformal radiation 
therapy for CNS and other 
pediatric tumors: minimizing 
toxicity and achieving a 
cure," University of Mon- 
treal/McGill, Montreal, 
Canada, March 3 and 4. 
Biello Lecture 
Jamshid Maddahi, MD, director of the Clinical PET Center 
at the University of California, Los Angeles, was invited lec- 
turer for the Thirteenth Annual Daniel R. Biello Memorial 
Lecture on March 8. Dr. Maddahi spoke on "State-of-the-art 
clinical applications of cardiovascular nuclear medicine: 
diagnosis, prognosis, and myocardial viability." At left is 
Barry Siegel, MD, director of the Division of Nuclear Medi- 
cine and coordinator of the Biello Lecture. 
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Tom Miller, MD, PhD, pro- 
fessor of radiology and of 
electrical engineering, pre- 
sented "Iterative reconstruc- 
tion: its role in clinical 
practice today and tomor- 
row" at the Society of 
Nuclear Medicine Mid-Win- 
ter Symposium, Fort Laud- 
erdale, Florida, Feburary 8 
and 9. 
Scott Mirowitz, MD, asso- 
ciate professor of radiology, 
radiologist-in-chief at 
Barnes Jewish Hospital 
north, and codirector of 
body magnetic resonance 
imaging, as guest speaker, 
spoke on "Diagnostic pitfalls 
in abdominal MRI," "MRI 
artifacts: challenges and 
solutions," "MRI of the rota- 
tor cuff," and "Pitfalls in 
knee MRI" at the Johns Hop- 
kins School of Medicine MRI 
Course, Marco Island, 
Florida, March 13 and 14. 
Eduardo Moros, PhD, 
assistant professor of radiol- 
ogy, presented "Use of A- 
scan for penetration control 
during dual-frequency ultra- 
sound thermal therapy of 
superficial tissues overlaying 
bone and lung" at BiOS '99 
International Symposium on 
Biomedical Optics, in con- 
nection with Photonics West 
99, sponsored by The Inter- 
national Society for Optical 
Engineering, San Jose, Cali- 
fornia, January 23 - 29. 
Vamsidhar Narra, MD, 
instructor in radiology, 
spoke on "Vascular MRA" at 
the Vascular Surgery/Inter- 
ventional Radiology Grand 
Rounds, Washington Univer- 
sity, St. Louis, Missouri, Jan- 
uary 25. He presented "MRI 
of focal hepatic lesions," 
"MRI of female pelvis," "3D 
contrast enhanced MR 
Vo receives academic 
fellowship 
Katie Vo, MD, a fellow in neuroradiology, is one of 
only four radiology investigators nationwide to 
receive a 1999 GE-AUR Radiology Research Academic 
Fellowship. The award was presented for her 
research on "Interventions to improve physician per- 
formance in interpreting cranial computed tomogra- 
phy scans of acute ischemic stroke patients." 
The two-year fellowship provides a $50,000 
annual stipend and is sponsored by the Association of 
University Radiologists and General Electric Medical 
Systems, a leading supplier of medical diagnostic 
imaging technology. GE-AUR fellowships encourage 
young investigators to pursue careers in radiology 
research by allowing them to devote a substantial 
amount of time to scientific projects in health out- 
comes, technology assessment, and related areas. 
angiography," and "MR 
cholangiopancreatography" 
at the Eastern Virginia Med- 
ical School, Norfolk, Febru- 
ary 11 and 12. 
Carlos Perez, MD, profes- 
sor of radiology and director 
of the Radiation Oncology 
Center, spoke on "Three- 
dimensional conformal radi- 
ation therapy and hormone 
therapy in localized carci- 
noma of the prostate" at the 
First Annual Palm Beach 
Cancer Symposium, Palm 
Beach, Florida, February 4 - 
7. He presented "Radiation 
therapy in the management 
of carcinoma of the uterine 
cervix" at the Cleveland 
Clinic, Cleveland, Ohio, Feb- 
ruary 26. 
James Purdy, PhD, profes- 
sor of radiology, associate 
director of the Radiation 
Oncology Center, and chief 
of radiation oncology 
physics, as a faculty mem- 
ber, presented "3-D treat- 
ment planning and 
conformal therapy" and 
"Quality assurance for 3-D 
conformal therapy" at the 
Intensity Modulated Radia- 
tion Therapy Meeting, Rome, 
Italy, February 18 - 22. As 
invited speaker, he spoke on 
"3-D treatment planning and 
conformal therapy: prob- 
lems and pitfalls" at the Uni- 
versity of Wisconsin, 
Madison, March 22. 
Marcus Raichle, MD, pro 
fessor of radiology and of 
neurology and neurobiology , 
and codirector of the Divi-    ' 
sion of Radiological Sci- 
ences, presented "The 
neural correlates of con- 
sciousness" at the Salk Insti- 
tute, San Diego, California, 
Feburary 1. He spoke on 
"Recent advances in neu- 
roimaging" at Hypoxia 99, 
Jasper, Alberta, Canada, 
March 1. 
Joseph Roti Roti, PhD, 
professor of radiology, asso- 
ciate director of the Radia- 
tion Oncology Center, and 
chief of cancer biology, pre- 
sented "Nuclear matrix-DNA 
interactions and the sensitiv- 
ity of mammalian cells to 
ionizing radiation" and "Sub- 
cellular localization of DNA 
damage and repair: How 
close can we look?" at the 
Cellular Localization of 
Repair and Effects of Bound 
Proteins Session, The Gor- 
don Conference, Ventura, 
California, February 7 -12. 
Stuart Sagel, MD, profes- 
sor of radiology, chief of 
chest radiology, and codirec- 
tor of body computed 
tomography, spoke on "Heli- 
cal CT in the thorax," "CT 
angiography for pulmonary 
embolism," "Digital chesi 
radiography," "HRCT of the 
pulmonary parenchyma," 
"CT of focal lung lesions, 
"CT: anatomic variations 
and pitfalls in the thorax, 
and "CT in bronchogenic 
carcinoma" at the Intern; 
tional Radiology Sympo- 
sium, Sydney, Australia, 
March 22 - 28. 
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Barry Siegel, MD, profes- 
Mor of radiology and of medi- 
■pne and director of the 
Division of Nuclear Medi- 
Kine, spoke on "New tech- 
nologies—PET scanning in 
_he staging of thoracic malig- 
aancies" and "PET to assess 
tie biology of thoracic 
tialignancies" at the 12th 
nnual Meeting of General 
horacic Surgical Club, 
/larco Island, Florida, March 
11 -14. 
arilyn Siegel, MD, pro- 
fessor of radiology and of 
)ediatrics, presented 
Neonatal cranial sonogra- 
hy" at the Pacific North- 
est Ultrasound Society 
:eeting, Seattle, Washing- 
ion, January 21. As visiting 
est lecturer, she presented 
Ultrasonography of pedi- 
,tric abdominal masses" at 
e University of Washing- 
;on, Seattle, January 21. 
liegel spoke on "Ultrasonog- 
raphy of the acute abdomen 
i children" at the Arkansas 
onographer's Society, 
'ayetteville, January 30. As 
the invited Hooshang Taybi 
honorary Lecturer, she pre- 
ented "Practical applica- 
ons of MR imaging in the 
fpediatric patient" at Chil- 
dren's Oakland Hospital, 
Oakland, California, Febru- 
ary 9. Siegel spoke on 
"Neonatal pulmonary dis- 
ease" and "Genitourinary 
anomalies and infections" at 
the University of California, 
San Francisco Resident 
Review Course, February 10. 
She presented "Ultrasonog- 
raphy of the pediatric chest" 
at the American Institute of 
Medicine Annual Meeting, 
San Antonio, Texas, March 
14 and 15. As invited lec- 
turer, Siegel spoke on "Ultra- 
sonography of the acute 
pediatric abdomen" at the 
University of Texas Health 
Science Center, San Anto- 
nio, March 15. 
Douglas Spitz, PhD, assis- 
tant professor of radiology, 
spoke on "Glucose depriva- 
tion-induced oxidative stress 
in human tumor cells" at the 
Graduate Center for Toxicol- 
ogy Research Seminar, Uni- 
versity of Kentucky, 
Lexington, January 25 and 
26; at the Department of 
Radiation Oncology 
Research Seminar, Univer- 
sity of Pennsylvania, 
Philadelphia, February 10 
and 11; and at the Society of 
Toxicology 38th Annual 
Meeting, New Orleans, 
Louisiana, March 15 -18. 
Match Day results announced 
In June, 15 physicians will begin their first year of 
training in the Institute's Diagnostic Radiology Resi- 
dency Program. The results were announced on the 
annual Match Day when senior medical students in 
the United States learn which residency programs 
they will enter in the upcoming academic year. Of the 
new MIR trainees, three received medical degrees 
from Duke University, two from Washington Univer- 
sity, two from the University of Wisconsin, and one 
each from Georgetown, Emory, Johns Hopkins, Yale, 
Dartmouth, New York University, Boston University, 
and the University of Missouri-Columbia. 
Todd Wasserman, MD, 
professor of radiology, pre- 
sented "Protection of normal 
tissue from toxicity" (an 
educational program spon- 
sored by The Institute for 
Continuing Healthcare Edu- 
cation and supported by 
MediCom of Princeton, Inc. 
and Alza Pharmaceuticals), 
St. Louis, Missouri, February 
24. He presented "Com- 
bined chemotherapy and 
radiotherapy for Hodgkin's 
disease" and "Combined 
chemotherapy and radio- 
therapy for non-Hodgkin's 
lymphoma" to the Texas 
Radiology Society, Dallas, 
April 9. 
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SYMPOSIA 
In this section ofFYI, only those faculty and staff who have 
MIR appointments are listed. 
MEDICAL IMAGING 1999 
Sponsored by The Interna- 
tional Society for Optical 
Engineering (SPIE) 
San Diego, California 
February 20 - 26, 1999 
James Blaine, DSc, techni- 
cal conference cochair, 
"PACS design and evalua- 
tion: engineering and clini- 
cal issues." 
Gilbert Jost, MD, panel 
member, PACS Keynote Ses- 
sion, "PACS: now or never." 
WORKSHOP 
Gilbert Jost, MD, instruc- 




MD; Jay Heiken, MD; 
Dennis Balfe, MD; Daniel 
Hirselj, BS; Thomas Pil- 
gram, PhD, "Spiral CT 
colography (virtual 
colonoscopy): multiobserver 
study of different image dis- 
play techniques compared to 
colonoscopy." 
Elizabeth McFarland, MD, 
"Colon unraveling based on 
electrical field—recent 
progress and further work." 
Bruce Whiting, PhD; Eliz- 
abeth McFarland, MD; 
Casey Dellabarca, BS; 
Barry Brunsden, "Study of 
CT artifacts in virtual 
colonoscopy." 
Bruce Whiting, PhD; 
Richard Slone, MD; 
Edward Muka, MSE, 
"Dynamic viewing protocols 
for diagnostic image 
evaluation." 
Bruce Whiting, PhD, "Sta- 
tistically lossless image com- 
pression for CR and DR." 
POSTER SESSIONS 
Edward Muka, MSE; 
Bruce Whiting, PhD, "The 
veiling glare point-spread 
function of medical imaging 
monitors." 
Edward Muka, MSE; 
Bruce Whiting, PhD, 
"Deploying CRT soft-copy 
displays in medical imaging 




217th Annual Meeting 
Anaheim, California 
March 21-25, 1999 
Carolyn Anderson, PhD, 
co-organizer, Bioconjugate 
Chemistry in Nuclear Medi- 
cine Symposium. 
SCIENTIFIC SESSIONS 
Carolyn Anderson, PhD; 
Laura Bass, PhD; Mar- 
garet Lanahan, MS, 
"Metabolism of radiometal- 
labeled octreotide analogs." 
David Reichert, PhD; 
Michael Welch, PhD, "Con- 
formational analysis of 
octreotide and indium 
bifunctional chelate 
conjugates." 
Michael Lewis, PhD; Car- 
olyn Anderson, PhD, "Eval- 
uation of copper-64-labeled 
anti-colorectal carcinoma 
monoclonal antibody conju- 
gate TETA-1A3." 
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David Gius, MD, PhD, instructor in radiology, 
was selected as the 1998 Radiation Oncol- 
ogy Teacher of the Year. The Teacher of the 
Year presentation is made annually in December 
to honor the Institute faculty member who 
makes a significant contribution to resident edu- 
cation during the academic year. Radiation 
oncology residents select the award recipient 
through a nomination and voting process. 
Gius joined the faculty in 1997 after com- 
pleting three years of training in radiation oncol- 
ogy at the Institute, including one year as an 
American Society for Therapeutic Radiology and 
Oncology Fellow. His medical and research 
background is extensive and impressive: med- 
ical degree from the Stritch School of Medicine 
at Loyola University of Chicago, doctoral degree 
from the University of Chicago, postdoctoral fel- 
lowships in molecular genetics and cell biology 
and in radiation and cellular oncology, a transi- 
tional internship at the the University of 
Chicago, and one year of residency at the Uni- 
versity of Michigan Medical Center. Gius cur- 
rently has a lab in the Radiation Oncology 
Center's cancer biology section where he is 
investigating the events that activate and repress 
cell division and growth. 
Since the award's inception in 1989, the fol- 
lowing faculty have been selected as teacher of 
the year: (1989) Susan Shapiro, MD; (1990) Car- 
los Perez, MD; (1991 and 1995) Perry Grigsby, 
MD; (1992) Jeff Michalski, MD; (1993) RusseU 
Gerber, MS; (1994) Mary Graham, MD; (1996) 
James Purdy, PhD; and (1997) Marie Taylor, MD. 
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